首页> 外文学位 >Controlled release formulation of 10-hydroxy-camptothecin using hydrophilic matrix system.
【24h】

Controlled release formulation of 10-hydroxy-camptothecin using hydrophilic matrix system.

机译:使用亲水性基质系统的10-羟基喜树碱控释制剂。

获取原文
获取原文并翻译 | 示例

摘要

The main objective of these studies was to formulate a controlled-released matrix system using Sodium CarboxymethylcelIulose as a hydrophilic polymeric carrier widely used in various pharmaceutical industries, to improve the performance of the matrix tablet containing the drug 10-hydroxycamptothecin (10HC). Efforts in formulating the drug are directed toward maintaining the lactone form of the drug for its potent antitumor activity which is known to be lost upon hydrolysis of the α-hydroxy-lactone ring of the drug.;In an effort to better understand the factors affecting the stability of the lactone form of 10HC and attain optimum formulation conditions, physicochemical characterization of the drug was conducted and several of the physical properties such as pKa, solubility and pH-depedent stability, were determined. The pKa determined was found to be 1.4.;The formulated solid dosage matrices were prepared by physical method in three forms that is, direct compression, wet granulation and lipid matrix formulation. Weight variance, hardness and disintegration tests were performed on the formulated matrices. Of all the matrices, the pH 1.2 granulation formulated matrix had the highest hardness of about 24 Lb and longest disintegration time >120 minutes.;In vitro studies were performed on the various matrices and their dissolution profiles compared based on the release rate and mechanisms. The pH 1.2 granulation matrix (F-5) and lipid formulation matrices (F-8, F-9 and F-10) release the drug with an almost zero-order release profile, while the rest of the formulated matrices yielded either Fickian or Anomalous drug release profile.;Data analysis indicated that the direct compression and the solvent evaporation method failed to prolong the release of the drug, that is, about 100% of the drug was released within 80 minutes in pH 1.2 dissolution media and 250 minutes in pH 6.8 dissolution media.;Analysis was also performed to predict the time for 80% release (t 80) of the drug as a function of the type of the formulation. More specifically, the drug released from the granulated formulation in pH 1.2 and pH 6.8 media were 50% and 80%, respectively, after 25 hours while about 95% of drug is released from the direct compression matrix system in about 4 hours in pH 6.8 dissolution media.;These results suggest that the most suitable formulation for the sustained release of 10-hydroxy-Camptothecin is the tablet matrix prepared with the method of granulation at pH 1.2 which gave an almost zero-order release profile.
机译:这些研究的主要目的是使用羧甲基甲基纤维素钠作为亲水性聚合物载体配制控释基质系统,该载体广泛用于各种制药行业,以改善含有药物10-羟基喜树碱(10HC)的基质片剂的性能。配制药物的努力是针对保持其内酯形式的有效抗肿瘤活性,已知该内酯形式会在药物的α-羟基内酯环水解后丧失。为了确定10HC内酯形式的稳定性并达到最佳配制条件,对药物进行了物理化学表征,并测定了一些物理性质,如pKa,溶解度和pH依赖的稳定性。测定的pKa为1.4。通过物理方法以直接压缩,湿法制粒和脂质基质制剂三种形式制备配制的固体剂型。在配制的基质上进行了重量变化,硬度和崩解测试。在所有基质中,pH 1.2制粒配方基质的最高硬度约为24 Lb,最长崩解时间> 120分钟。;根据释放速率和机理,对各种基质及其溶出曲线进行了体外研究。 pH 1.2的制粒基质(F-5)和脂质制剂基质(F-8,F-9和F-10)释放的药物几乎具有零级释放曲线,而其余的制剂基质则产生Fickian或Fickian异常的药物释放曲线。数据分析表明,直接压缩和溶剂蒸发方法不能延长药物的释放,即在pH 1.2溶出介质中80分钟内释放约100%的药物,而在pH 1.2溶出介质中250分钟内释放约250%。 pH 6.8溶出介质。还进行了分析,以预测80%的药物释放时间(t 80)与制剂类型有关。更具体地,在25小时后,在pH 1.2和pH 6.8介质中从粒状制剂中释放的药物分别为50%和80%,而在pH 6.8中,约95%的药物在约4小时内从直接压缩基质系统中释放。这些结果表明,用于持续释放10-羟基喜树碱的最合适的制剂是用制粒方法在pH 1.2下制备的片剂基质,该制剂几乎具有零级释放曲线。

著录项

  • 作者

    Osei-Owusu, Luke Kwabena.;

  • 作者单位

    Long Island University, The Brooklyn Center.;

  • 授予单位 Long Island University, The Brooklyn Center.;
  • 学科 Chemistry Pharmaceutical.;Health Sciences Pharmacy.
  • 学位 M.S.
  • 年度 2008
  • 页码 100 p.
  • 总页数 100
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号